Fierce Biotech Layoff Tracker 2024: Athira cuts 70% of workforce, including two execs; Charles River lays off 3% of workforce after Q2 revenue drop

We really didn’t want to have to create another Layoff Tracker this year. But here we are, launching the third annual iteration tracking industry layoffs. 

Last year, we tallied 187 total layoffs among biotech companies, a 57% jump compared to 119 in 2022. We hope that trend reverses itself in 2024.

As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team and let us know. 

September—8 companies

Sept. 17 – Athira Pharma: Just a couple of weeks after announcing that its Alzheimer’s candidate fosgonimeton failed to beat placebo in a phase 2/3 trial, Athira is laying off 70% of its staff and saying goodbye to several executives as it pivots to ATH-1105, an oral small molecule for amyotrophic lateral sclerosis. Story


Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks